Syquant Capital SAS’s Amicus Therapeutics FOLD Stock Holding History

Syquant Capital SAS’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25,000	Closed	-$362K	–	41
2026 Q1	$362K	Buy	+25,000	New	+$358K	0.06%	40

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Syquant Capital SAS's FOLD Position: Q2 2026 in Review

Syquant Capital SAS sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 25,000 shares — an estimated $362K sold.

Syquant Capital SAS first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $362K in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

Syquant Capital SAS reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Syquant Capital SAS sold 25,000 Amicus Therapeutics shares in Q2 2026, an estimated $362K.
Syquant Capital SAS first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
Syquant Capital SAS's Amicus Therapeutics position peaked at $362K in Q1 2026.
1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Syquant Capital SAS's 13F filing for Q2 2026, filed 9 Jul 2026.